Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
2.310
-0.060 (-2.53%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $21.83 million as of September 11, 2026. Its market cap has increased by 36.46% in one year.
Market Cap
21.83M
Enterprise Value
-10.63M
1-Year Change
36.46%
Ranking
Category
Stock Price
$2.31
ChartMarket Cap Chart
Since August 15, 2014, Cellectar Biosciences's market cap has increased from $9.20M to $21.83M, an increase of 137.33%. That is a compound annual growth rate of 7.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 21.80M | 74.40% |
| Dec 31, 2025 | 12.50M | 1.63% |
| Dec 31, 2024 | 12.30M | -63.82% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 154.35% |
| Aug 15, 2014 | 9.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Polyrizon | 23.87M |
| Longeveron | 23.37M |
| NanoViricides | 23.24M |
| Akari Therapeutics, | 22.00M |
| Jasper Therapeutics | 21.97M |
| Lantern Pharma | 21.86M |
| TScan Therapeutics | 21.72M |
| Palatin Technologies | 21.07M |